Clinical Trial Update: Comparison of Standard vs. Accelerated Corneal Crosslinking [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial comparing standard versus accelerated corneal crosslinking for keratoconus and corneal ectasia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Ectasia
• Keratoconus

Snippet

Sponsor: Price Vision Group | Conditions: Keratoconus, Ectasia Corneal | Phase 2, Phase 3 | Status: RECRUITING